| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 12 | -1,245,227 | 100% | $188.64 | -$234,898,302 |
| Net | -12 | -1,245,227 | -100% | -$234,898,302 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN, Director | $459,658,900 | -$37,212,391 | -7.5% | 04 Nov 2025 |
| ROELOF BOTHA | Director | $276,421,426 | -$17,708,936 | -6% | 24 Nov 2025 |
| JAMES HEALY | Director | $225,766,720 | 25 Apr 2025 | ||
| Jonathan Sheena | Director, CO-FOUNDER | $72,598,135 | -$17,615,320 | -20% | 20 Jan 2026 |
| Steven Leonard Chapman | CEO AND PRESIDENT, Director | $54,095,014 | -$82,605,501 | -60% | 20 Jan 2026 |
| DANIEL RABINOWITZ | Sec. And Chief Legal Officer | $53,719,697 | -$10,539,561 | -16% | 20 Jan 2026 |
| John Fesko | President, Chief Bus. Officer | $41,654,220 | -$6,480,674 | -13% | 20 Jan 2026 |
| Solomon Moshkevich | President, Clinicaldiagnostics | $34,004,265 | -$15,569,270 | -31% | 20 Jan 2026 |
| Michael Burkes Brophy | Chief Financial Officer | $16,449,880 | -$28,493,365 | -63% | 20 Jan 2026 |
| Robert Alan Schueren | Chief Operating Officer | $10,973,729 | 27 Jan 2023 | ||
| HERM ROSENMAN | Director | $4,660,250 | -$11,011,477 | -70% | 31 Oct 2025 |
| Roy D. Baynes | Director | $4,128,682 | -$2,809,689 | -40% | 19 Nov 2025 |
| Rowan E. Chapman | Director | $1,406,064 | -$1,520,612 | -52% | 05 Dec 2025 |
| Gail Boxer Marcus | Director | $1,352,691 | -$3,494,195 | -72% | 31 Oct 2025 |
| Todd C. Cozzens | Director | $1,053,729 | 25 May 2022 | ||
| Brinkley Ruth Williams | Director | $855,716 | 31 Oct 2025 | ||
| Monica Bertagnolli | Director | $840,424 | 31 Oct 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|